Jeff Yass’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
Other funds holding CUE
Jeff Yass's CUE Position: Q3 2026 in Review
Jeff Yass sold out of Cue Biopharma (CUE) in Q3 2026, closing a stake of 11,003 shares — an estimated $326K sold.
Jeff Yass first reported a position in CUE in Q2 2020 and held it in 22 quarters. The position peaked at $689K in Q1 2021. 58 funds tracked by Wall St. Rank hold CUE as of Q3 2026.
- Jeff Yass reported no remaining Cue Biopharma position as of Q3 2026 after selling out during the quarter.
- Jeff Yass sold 11,003 Cue Biopharma shares in Q3 2026, an estimated $326K.
- Jeff Yass first reported a position in Cue Biopharma in Q2 2020 and held it in 22 quarters.
- Jeff Yass's Cue Biopharma position peaked at $689K in Q1 2021.
- 58 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.